Caprock Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $259K | Buy |
2,346
+619
| +36% | +$68.5K | 0.01% | 921 |
|
|
2024
Q4 | $236K | Buy |
+1,727
| New | +$236K | 0.01% | 880 |
|
|
2024
Q3 | – | Sell |
-1,669
| Closed | -$230K | – | 954 |
|
|
2024
Q2 | $230K | Buy |
1,669
+109
| +7% | +$15K | 0.01% | 765 |
|
|
2024
Q1 | $215K | Buy |
+1,560
| New | +$215K | 0.01% | 659 |
|
|
2018
Q3 | – | Sell |
-2,712
| Closed | -$266K | – | 430 |
|
|
2018
Q2 | $266K | Sell |
2,712
-11
| -0.4% | -$1.08K | 0.06% | 318 |
|
|
2018
Q1 | $226K | Buy |
+2,723
| New | +$226K | 0.05% | 358 |
|